Chemomab Therapeutics Ltd. — Director's Dealing 2021

Mar 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Chemomab Therapeutics Ltd. (CMMB)
CIK: 0001534248
Period of Report: 2021-03-16

Reporting Person: Cohen Neil Harris (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-16	American Depositary Shares	P	2409	$41.51	Acquired	2409	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-16	Option to Purchase American Depositary Shares	$13.17	P	688	Acquired	2030-03-15	American Depositary Shares (688)	Direct

Footnotes

F1: The Reporting Person acquired, in a private placement transaction, 1,397 American Depositary Shares and received an additional 1,011 American Depositary Shares pursuant to anti-dilution rights.

F2: These options vest and become exercisable as follows: 1/3 vest on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service.